Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Childress

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Journal of Attention Disorders|June 29, 2012
The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trialAnn C Childress, Valerie Arnold, Ben Adeyi, et al.
Frontiers in Psychiatry|April 3, 2024
Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom studyAndrew J Cutler, Scott H Kollins, Matthew N Brams, et al.
Journal of Child and Adolescent Psychopharmacology|February 19, 2015
The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom StudyAnn C Childress, Matthew Brams, Andrew J Cutler, et al.
Journal of Child and Adolescent Psychopharmacology|April 10, 2026
Efficacy of Centanafadine for Executive Functioning and Learning Problems in Children and Adolescents with Attention-Deficit/Hyperactivity DisorderTimothy E Wilens, Dorothee Oberdhan, Na Jin, et al.
Journal of Child and Adolescent Psychopharmacology|January 12, 2022
Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 StudyAndrew J Cutler, Katsumi Suzuki, Brittney Starling, et al.
Proceedings. AMIA Symposium|February 3, 1999
Clinical event management using push technology--implementation and evaluation at two health care centersH R Warner, S Miller, K Jennings, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 1995
Water bolus for electron irradiation of the ear canalW H Morrison, P F Wong, G Starkschall, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|April 7, 2018
Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and interventionStephen V Faraone, Anthony L Rostain, Joseph Blader, et al.
Journal of Child and Adolescent Psychopharmacology|May 13, 2014
Participant-perceived quality of life in a long-term, open-label trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderAnn C Childress, Andrew J Cutler, Keith Saylor, et al.
Journal of Child and Adolescent Psychopharmacology|February 16, 2013
A long-term open-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderRobert L Findling, Andrew J Cutler, Keith Saylor, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of Attention Disorders|June 29, 2012
The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trialAnn C Childress, Valerie Arnold, Ben Adeyi, et al.
Frontiers in Psychiatry|April 3, 2024
Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom studyAndrew J Cutler, Scott H Kollins, Matthew N Brams, et al.
Journal of Child and Adolescent Psychopharmacology|February 19, 2015
The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom StudyAnn C Childress, Matthew Brams, Andrew J Cutler, et al.
Journal of Child and Adolescent Psychopharmacology|April 10, 2026
Efficacy of Centanafadine for Executive Functioning and Learning Problems in Children and Adolescents with Attention-Deficit/Hyperactivity DisorderTimothy E Wilens, Dorothee Oberdhan, Na Jin, et al.
Journal of Child and Adolescent Psychopharmacology|January 12, 2022
Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 StudyAndrew J Cutler, Katsumi Suzuki, Brittney Starling, et al.
Proceedings. AMIA Symposium|February 3, 1999
Clinical event management using push technology--implementation and evaluation at two health care centersH R Warner, S Miller, K Jennings, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 1995
Water bolus for electron irradiation of the ear canalW H Morrison, P F Wong, G Starkschall, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|April 7, 2018
Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and interventionStephen V Faraone, Anthony L Rostain, Joseph Blader, et al.
Journal of Child and Adolescent Psychopharmacology|May 13, 2014
Participant-perceived quality of life in a long-term, open-label trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderAnn C Childress, Andrew J Cutler, Keith Saylor, et al.
Journal of Child and Adolescent Psychopharmacology|February 16, 2013
A long-term open-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderRobert L Findling, Andrew J Cutler, Keith Saylor, et al.
Pageof 9